EPG5 and Parkinson disease: Notably, we were able to show α‐synuclein overexpression through SNCA mRNA abundance in the cell line from the patient with EPG5‐related parkinsonism, as well as in the 2 cell lines from EPG5‐mutated patients with milder, primarily neurodevelopmental disorders.